Literature DB >> 6762684

Effects by nifedipine on thromboxane synthesis in vitro and in vivo.

G Davì, S Novo, M Fiore, A Foderà, A Mattina, A Mazzola, A Strano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6762684     DOI： 10.1016/0049-3848(82)90110-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  8 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?

Authors:  J A Foley; R C Becker
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  The effect of nifedipine, nimodipine and nisoldipine on agonist- and trauma-stimulated vascular prostacyclin synthesis in vitro.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

4.  [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands].

Authors:  K Schrör; G Latta; H Darius; W Klaus; R Ziegler
Journal:  Klin Wochenschr       Date:  1985-01-02

5.  Inhibition of phospholipase A2 (PLA2) activity by nifedipine and nisoldipine is independent of their calcium-channel-blocking activity.

Authors:  J Chang; E Blazek; R P Carlson
Journal:  Inflammation       Date:  1987-09       Impact factor: 4.092

6.  The effect of nifedipine alone or combined with low dose acetylsalicyclic acid on endotoxin-induced pulmonary hypertension in the piglet.

Authors:  D Schranz; R G Huth; H Stopfkuchen; B K Jüngst
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

7.  Inhibition of human platelet functions by cyclandelate.

Authors:  W E van den Hoven; D W Hall
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Effects of organic and inorganic Ca antagonists on rat platelet arachidonic acid metabolism in the presence of Ca2+, Sr2+ and Ba2+.

Authors:  D Blache; M Ciavatti
Journal:  Mol Cell Biochem       Date:  1989-02-21       Impact factor: 3.396
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.